Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 4, 2008, Pages 312-314

  Holvoet, Paul ^a   Sinnaeve, Peter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

atherosclerosis; kinases; migration; restenosis; smooth muscle cell

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIO ASSOCIATED MIGRATORY CELL PROTEIN; ANGIO ASSOCIATED MIGRATORY CELL PROTEIN ANTIBODY; CELL PROTEIN; FASUDIL; PROTEIN ANTIBODY; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CELL MOVEMENT; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ANTIGEN, B-CELL; RISK FACTORS; TUNICA INTIMA;

EID: 46849083482     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.024     Document Type: Editorial

References (33)

1. Blindt R., Krott N., Hanrath P., vom Dahl J., van Eys G., and Bosserhoff A.K. Expression patterns of integrins on quiescent and invasive smooth muscle cells and impact on cell locomotion. J Mol Cell Cardiol 34 (2002) 1633-1644
2. Blindt R., Vogt F., Lamby D., et al. Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vasc Res 39 (2002) 340-352
3. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999) S419-S420
4. Beckner M.E., Krutzsch H.C., Stracke M.L., Williams S.T., Gallardo J.A., and Liotta L.A. Identification of a new immunoglobulin superfamily protein expressed in blood vessels with a heparin-binding consensus sequence. Cancer Res 55 (1995) 2140-2149
5. Vogt F., Zernecke A., Beckner M., et al. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. J Am Coll Cardiol 52 (2008) 302-311
6. Loirand G., Guerin P., and Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98 (2006) 322-334
7. Cordle A., Koenigsknecht-Talboo J., Wilkinson B., Limpert A., and Landreth G. Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 280 (2005) 34202-34209
8. Beckner M.E., Jagannathan S., and Peterson V.A. Extracellular angio-associated migratory cell protein plays a positive role in angiogenesis and is regulated by astrocytes in coculture. Microvasc Res 63 (2002) 259-269
9. Martin C.B., Mahon G.M., Klinger M.B., et al. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 20 (2001) 1953-1963
10. Yin L., Morishige K., Takahashi T., et al. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Mol Cancer Ther 6 (2007) 1517-1525
11. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998) 1129-1135
12. Laufs U., and Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273 (1998) 24266-24271
13. Abe K., Shimokawa H., Morikawa K., et al. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94 (2004) 385-393
14. Seko T., Ito M., Kureishi Y., et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92 (2003) 411-418
15. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
16. Hattori T., Shimokawa H., Higashi M., et al. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Circ Res 94 (2004) 46-52
17. Kandabashi T., Shimokawa H., Miyata K., et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 101 (2000) 1319-1323
18. Mallat Z., Gojova A., Sauzeau V., et al. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 93 (2003) 884-888
19. Matsumoto Y., Uwatoku T., Oi K., et al. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 24 (2004) 181-186
20. Sawada N., Itoh H., Ueyama K., et al. Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101 (2000) 2030-2033
21. Masumoto A., Mohri M., Shimokawa H., Urakami L., Usui M., and Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105 (2002) 1545-1547
22. Mohri M., Shimokawa H., Hirakawa Y., Masumoto A., and Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 41 (2003) 15-19
23. Vicari R.M., Chaitman B., Keefe D., et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol 46 (2005) 1803-1811
24. Kishi T., Hirooka Y., Masumoto A., et al. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure. Circulation 111 (2005) 2741-2747
25. Nohria A., Grunert M.E., Rikitake Y., et al. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 99 (2006) 1426-1432
26. Kozai T., Eto M., Yang Z., Shimokawa H., and Luscher T.F. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Cardiovasc Res 68 (2005) 475-482
27. Noma K., Oyama N., and Liao J.K. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 290 (2006) C661-C668
28. Avkiran M., Rowland A.J., Cuello F., and Haworth R.S. Protein kinase d in the cardiovascular system: emerging roles in health and disease. Circ Res 102 (2008) 157-163
29. Jacobs M., Hayakawa K., Swenson L., et al. The structure of dimeric ROCK I reveals the mechanism for ligand selectivity. J Biol Chem 281 (2006) 260-268
30. Beckner M.E., Krutzsch H.C., Klipstein S., et al. AAMP, a newly identified protein, shares a common epitope with alpha-actinin and a fast skeletal muscle fiber protein. Exp Cell Res 225 (1996) 306-314
31. Luscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
32. Kim J.S., Kim J.G., Moon M.Y., et al. Transforming growth factor-beta1 regulates macrophage migration via RhoA. Blood 108 (2006) 1821-1829
33. Cui R., Tieu B., Recinos A., Tilton R.G., and Brasier A.R. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ Res 99 (2006) 723-730